James C. Edgemond's most recent trade in United Therapeutics Corp was a trade of 3,517 Common Stock done at an average price of $146.0 . Disclosure was reported to the exchange on Dec. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 15 Dec 2025 | 3,517 | 11,659 (0%) | 0% | 146.0 | 513,588 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 3,517 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 492.81 per share. | 15 Dec 2025 | 840 | 10,659 (0%) | 0% | 492.8 | 413,958 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 493.70 per share. | 15 Dec 2025 | 561 | 10,098 (0%) | 0% | 493.7 | 276,968 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 495.90 per share. | 15 Dec 2025 | 520 | 9,218 (0%) | 0% | 495.9 | 257,869 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 498.09 per share. | 15 Dec 2025 | 395 | 8,623 (0%) | 0% | 498.1 | 196,745 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 495.02 per share. | 15 Dec 2025 | 360 | 9,738 (0%) | 0% | 495.0 | 178,206 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 500.30 per share. | 15 Dec 2025 | 241 | 8,142 (0%) | 0% | 500.3 | 120,573 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 499.31 per share. | 15 Dec 2025 | 240 | 8,383 (0%) | 0% | 499.3 | 119,835 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 496.98 per share. | 15 Dec 2025 | 200 | 9,018 (0%) | 0% | 497.0 | 99,395 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 491.52 per share. | 15 Dec 2025 | 160 | 11,499 (0%) | 0% | 491.5 | 78,644 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 21,000 | 3,517 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 08 Dec 2025 | 21,000 | 29,142 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 477.18 per share. | 08 Dec 2025 | 6,529 | 19,256 (0%) | 0% | 477.2 | 3,115,502 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 477.97 per share. | 08 Dec 2025 | 3,295 | 15,961 (0%) | 0% | 478.0 | 1,574,907 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 479.16 per share. | 08 Dec 2025 | 3,139 | 12,822 (0%) | 0% | 479.2 | 1,504,074 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 476.17 per share. | 08 Dec 2025 | 2,957 | 25,785 (0%) | 0% | 476.2 | 1,408,046 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 480.03 per share. | 08 Dec 2025 | 1,559 | 11,263 (0%) | 0% | 480.0 | 748,369 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 483.29 per share. | 08 Dec 2025 | 742 | 9,521 (0%) | 0% | 483.3 | 358,599 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 484.51 per share. | 08 Dec 2025 | 739 | 8,782 (0%) | 0% | 484.5 | 358,053 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 482.22 per share. | 08 Dec 2025 | 523 | 10,263 (0%) | 0% | 482.2 | 252,199 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 486.71 per share. | 08 Dec 2025 | 520 | 8,142 (0%) | 0% | 486.7 | 253,090 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 481.22 per share. | 08 Dec 2025 | 477 | 10,786 (0%) | 0% | 481.2 | 229,544 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 475.08 per share. | 08 Dec 2025 | 400 | 28,742 (0%) | 0% | 475.1 | 190,034 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 484.85 per share. | 08 Dec 2025 | 120 | 8,662 (0%) | 0% | 484.9 | 58,182 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 01 Dec 2025 | 21,000 | 29,142 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 20,483 | 24,517 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 479.92 per share. | 01 Dec 2025 | 7,552 | 14,539 (0%) | 0% | 479.9 | 3,624,368 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 479.11 per share. | 01 Dec 2025 | 4,198 | 22,091 (0%) | 0% | 479.1 | 2,011,284 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 480.95 per share. | 01 Dec 2025 | 3,858 | 10,681 (0%) | 0% | 480.9 | 1,855,492 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 477.98 per share. | 01 Dec 2025 | 2,853 | 26,289 (0%) | 0% | 478.0 | 1,363,672 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 481.80 per share. | 01 Dec 2025 | 1,476 | 9,205 (0%) | 0% | 481.8 | 711,143 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 483.04 per share. | 01 Dec 2025 | 903 | 8,302 (0%) | 0% | 483.0 | 436,188 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 517 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 484.68 per share. | 01 Dec 2025 | 160 | 8,142 (0%) | 0% | 484.7 | 77,549 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 24 Nov 2025 | 21,000 | 29,142 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 21,000 | 517 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 477.22 per share. | 24 Nov 2025 | 2,989 | 11,652 (0%) | 0% | 477.2 | 1,426,403 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 470.22 per share. | 24 Nov 2025 | 2,919 | 21,861 (0%) | 0% | 470.2 | 1,372,575 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 471.88 per share. | 24 Nov 2025 | 1,971 | 19,890 (0%) | 0% | 471.9 | 930,076 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 468.29 per share. | 24 Nov 2025 | 1,850 | 26,332 (0%) | 0% | 468.3 | 866,330 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 472.73 per share. | 24 Nov 2025 | 1,788 | 18,102 (0%) | 0% | 472.7 | 845,233 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 478.14 per share. | 24 Nov 2025 | 1,630 | 10,022 (0%) | 0% | 478.1 | 779,362 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 476.09 per share. | 24 Nov 2025 | 1,621 | 14,641 (0%) | 0% | 476.1 | 771,745 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 475.11 per share. | 24 Nov 2025 | 1,560 | 16,262 (0%) | 0% | 475.1 | 741,168 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 469.34 per share. | 24 Nov 2025 | 1,552 | 24,780 (0%) | 0% | 469.3 | 728,414 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 467.35 per share. | 24 Nov 2025 | 960 | 28,182 (0%) | 0% | 467.4 | 448,658 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 481.55 per share. | 24 Nov 2025 | 794 | 8,273 (0%) | 0% | 481.6 | 382,354 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 480.71 per share. | 24 Nov 2025 | 640 | 9,067 (0%) | 0% | 480.7 | 307,655 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 478.73 per share. | 24 Nov 2025 | 315 | 9,707 (0%) | 0% | 478.7 | 150,800 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 473.54 per share. | 24 Nov 2025 | 280 | 17,822 (0%) | 0% | 473.5 | 132,592 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 482.30 per share. | 24 Nov 2025 | 131 | 8,142 (0%) | 0% | 482.3 | 63,181 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 10,688 | 21,517 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 17 Nov 2025 | 10,688 | 18,806 (0%) | 0% | 146.0 | 1,560,769 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 17 Nov 2025 | 10,312 | 18,430 (0%) | 0% | 146.0 | 1,505,861 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 10,312 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 469.39 per share. | 17 Nov 2025 | 4,558 | 8,555 (0%) | 0% | 469.4 | 2,139,487 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 468.33 per share. | 17 Nov 2025 | 4,107 | 13,113 (0%) | 0% | 468.3 | 1,923,425 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 470.34 per share. | 17 Nov 2025 | 3,591 | 15,215 (0%) | 0% | 470.3 | 1,688,978 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 471.22 per share. | 17 Nov 2025 | 2,657 | 12,558 (0%) | 0% | 471.2 | 1,252,030 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 472.13 per share. | 17 Nov 2025 | 1,999 | 10,559 (0%) | 0% | 472.1 | 943,786 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 467.52 per share. | 17 Nov 2025 | 1,090 | 17,220 (0%) | 0% | 467.5 | 509,602 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 473.68 per share. | 17 Nov 2025 | 920 | 9,639 (0%) | 0% | 473.7 | 435,783 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 475.89 per share. | 17 Nov 2025 | 798 | 8,202 (0%) | 0% | 475.9 | 379,761 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 474.80 per share. | 17 Nov 2025 | 639 | 9,000 (0%) | 0% | 474.8 | 303,397 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 470.34 per share. | 17 Nov 2025 | 437 | 8,118 (0%) | 0% | 470.3 | 205,537 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 464.38 per share. | 17 Nov 2025 | 120 | 18,310 (0%) | 0% | 464.4 | 55,726 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 476.48 per share. | 17 Nov 2025 | 84 | 8,118 (0%) | 0% | 476.5 | 40,024 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 21,000 | 10,312 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 10 Nov 2025 | 21,000 | 29,118 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 453.81 per share. | 10 Nov 2025 | 4,633 | 14,050 (0%) | 0% | 453.8 | 2,102,517 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 448.33 per share. | 10 Nov 2025 | 3,356 | 23,171 (0%) | 0% | 448.3 | 1,504,595 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 454.82 per share. | 10 Nov 2025 | 3,342 | 10,708 (0%) | 0% | 454.8 | 1,519,994 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 455.83 per share. | 10 Nov 2025 | 2,590 | 8,118 (0%) | 0% | 455.8 | 1,180,598 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 452.76 per share. | 10 Nov 2025 | 2,170 | 18,683 (0%) | 0% | 452.8 | 982,479 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 447.47 per share. | 10 Nov 2025 | 1,539 | 26,527 (0%) | 0% | 447.5 | 688,655 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 451.87 per share. | 10 Nov 2025 | 1,065 | 20,853 (0%) | 0% | 451.9 | 481,240 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 446.51 per share. | 10 Nov 2025 | 1,052 | 28,066 (0%) | 0% | 446.5 | 469,727 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 449.00 per share. | 10 Nov 2025 | 653 | 22,518 (0%) | 0% | 449 | 293,197 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 450.80 per share. | 10 Nov 2025 | 600 | 21,918 (0%) | 0% | 450.8 | 270,480 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2025 | 21,000 | 31,312 | - | - | Stock Options | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 04 Nov 2025 | 21,000 | 29,118 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 436.78 per share. | 04 Nov 2025 | 7,317 | 11,350 (0%) | 0% | 436.8 | 3,195,910 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 435.81 per share. | 04 Nov 2025 | 6,088 | 18,667 (0%) | 0% | 435.8 | 2,653,239 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 437.74 per share. | 04 Nov 2025 | 2,752 | 8,598 (0%) | 0% | 437.7 | 1,204,662 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 434.96 per share. | 04 Nov 2025 | 1,679 | 24,755 (0%) | 0% | 435.0 | 730,302 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 433.78 per share. | 04 Nov 2025 | 1,512 | 26,434 (0%) | 0% | 433.8 | 655,872 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 432.86 per share. | 04 Nov 2025 | 1,074 | 27,946 (0%) | 0% | 432.9 | 464,892 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 438.50 per share. | 04 Nov 2025 | 360 | 8,238 (0%) | 0% | 438.5 | 157,859 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 439.51 per share. | 04 Nov 2025 | 120 | 8,118 (0%) | 0% | 439.5 | 52,741 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 432.09 per share. | 04 Nov 2025 | 98 | 29,020 (0%) | 0% | 432.1 | 42,345 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 12,000 | 87,500 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 09 Jun 2025 | 12,000 | 20,118 (0%) | 0% | 117.8 | 1,413,120 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.20 per share. | 09 Jun 2025 | 7,700 | 8,418 (0%) | 0% | 325.2 | 2,504,068 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.44 per share. | 09 Jun 2025 | 3,595 | 16,523 (0%) | 0% | 325.4 | 1,169,955 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.56 per share. | 09 Jun 2025 | 305 | 16,218 (0%) | 0% | 326.6 | 99,602 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 326.81 per share. | 09 Jun 2025 | 300 | 8,118 (0%) | 0% | 326.8 | 98,042 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 328.28 per share. | 09 Jun 2025 | 100 | 16,118 (0%) | 0% | 328.3 | 32,828 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 02 Jun 2025 | 12,000 | 20,118 (0%) | 0% | 117.8 | 1,413,120 | Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 12,000 | 99,500 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Sale of securities on an exchange or to another person at price $ 325.59 per share. | 02 Jun 2025 | 5,347 | 10,771 (0%) | 0% | 325.6 | 1,740,929 | Common Stock |